• 1
    Löhr HF, Gerken G, Schlicht HJ et al. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B. J Infect Dis 1993; 168: 11339.
  • 2
    Ferrari C, Penna A, Bertoletti A et al. Cellular immune responses to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1990; 145: 34429.
  • 3
    Tsai SL, Chen PJ, Lai MY et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J Clin Invest 1992; 89: 8796.
  • 4
    Rehermann B, Fowler P, Sidney J et al. The cytotoxic-T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995; 181: 104758.
  • 5
    Milich DR, McLachlan A. The nucleocapsid of hepatitis B virus is both a T cell-independent and T cell-dependent antigen. Science 1986; 234: 1398401.
  • 6
    Milich DR, Schödel F, Hughes JL et al. The hepatitis B virus core and e antigens elicit different Th cell subsets; antigen structure can affect Th cell phenotype. J Virol 1997; 71: 2192201.
  • 7
    Schödel F, Moriarty AM, Peterson DL et al. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J Virol 1992; 66: 10614.
  • 8
    Fiorentino DF, Zlotnik A, Vieira P et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 344451.
  • 9
    Yue FY, Dummer R, Geertsen R et al. Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class Ι, HLA class ΙΙ and ICAM-Ι molecules. Int J Cancer 1997; 71: 6307.
  • 10
    Tsuruma T, Yagihashi A, Torigoe T et al. Interleukin-10 reduces natural killer sensitivity and downregulates MHC class Ι expression on H-ras-transformed cells. Cell Immunol 1998; 184: 1218.
  • 11
    Kundu N, Fulton AM. Interleukin-10 inhibits tumor metastasis, downregulates MHC class Ι and enhances NK lysis. Cell Immunol 1997; 180: 5561.
  • 12
    Knolle PA, Uhrig A, Hegenbarth S et al. IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin Exp Immunol 1998; 114: 42733.
  • 13
    De Waal Malefyt R, Haanan J, Spits H et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class-ΙΙ major histocompatibility complex expression. J Exp Med 1991; 174: 91524.
  • 14
    De Waal Malefyt R, Abrams J, Bennett B et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 120920.
  • 15
    Hyodo N, Tajimi M, Ugajin T et al. Frequencies of interferon-γ and interleukin-10 secreting cells in peripheral blood mononuclear cells and liver infiltrating lymphocytes in chronic hepatitis B virus infection. Hepatol Res 2003; 27: 10916.
  • 16
    Vingerhoets J, Michielsen P, Vanham G et al. HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B. J Hepatol 1998; 28: 816.
  • 17
    Schlaak JF, Tully G, Löhr HF et al. HBV specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines. Clin Exp Immunol 1999; 115: 50814.
  • 18
    Rico MA, Quiroga JA, Subira D et al. Hepatitis B virus-specific T cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. Hepatology 2001; 33: 295300.
  • 19
    Sato K, Yamashita N, Matsuyama T. Human peripheral blood monocyte-derived interleukin-10-induced semi-mature dendritic cells induce anergic CD4 (+) and CD8 (+) T cells via presentation of the internalized soluble antigen and cross-presentation of the phagocytosed necrotic cellular fragments. Cell Immunol 2002; 215: 18694.
  • 20
    Steinbrink K, Graulich E, Kubsch S et al. CD4 (+) and CD8 (+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 2002; 99: 246876.
  • 21
    Akbar SM, Onji M, Inaba K et al. Low responsiveness of hepatitis B virus-transgenic mice in antibody response to T cell-dependent antigen: defect in antigen-presenting activity of dendritic cells. Immunology 1993; 78: 46875.
  • 22
    Wang FS, Xing LH, Liu MX et al. Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J Gastroenterol 2001; 7: 53741.
  • 23
    Cerwenka A, Morgan TM, Harmsen AG et al. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J Exp Med 1999; 189: 42334.
  • 24
    Salgame P, Abrams JS, Clayberger C et al. Differing lymphokine profiles of functional subsets of human CD4+ and CD8+ T cell clones. Science 1991; 254: 27982.
  • 25
    Maggi E, Giudizi MG, Biagiotti R et al. Th-2 like CD8+ T cells showing B-cell helper function and reduced cytolytic activity in human immunodeficiency virus type I infection. J Exp Med 1994; 180: 48995.
  • 26
    Wirth S, Van Den Broek M, Frossard CP et al. CD8 (+) T cells secreting type 2 lymphokines are defective in protection against viral infection. Cell Immunol 2000; 202: 1322.
  • 27
    Prezzi C, Casciaro MA, Francavilla V et al. Virus-specific CD8 (+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection. Eur J Immunol 2001; 31: 894906.
  • 28
    Santin AD, Hermonat PL, Ravaggi A et al. Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8+ cytotoxic T lymphocytes. J Virol 2000; 74: 472937.